Deep Dive Into Zoetis Stock: Analyst Perspectives (4 Ratings)
Portfolio Pulse from Benzinga Insights
Zoetis (NYSE:ZTS) has received mixed analyst ratings over the past three months, with all four analysts maintaining a 'Buy' rating but lowering their price targets. The average 12-month price target is now $205.25, down 4.98%. Zoetis has shown strong financial performance with a 9.5% revenue growth rate, a 27.35% net margin, and a high ROE of 11.91%. However, the company faces challenges with a high debt-to-equity ratio of 1.34.
July 25, 2024 | 12:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Zoetis has received mixed analyst ratings with all four analysts maintaining a 'Buy' rating but lowering their price targets. The average 12-month price target is now $205.25, down 4.98%. Despite strong financial performance, the high debt-to-equity ratio remains a concern.
The mixed analyst ratings and lowered price targets suggest a neutral short-term impact on Zoetis's stock price. While the company's strong financial performance is a positive indicator, the high debt-to-equity ratio poses a potential risk, balancing the overall outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100